CAVE CREEK, Ariz., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Endexx Corporation (OTC PINK: EDXC), announced today that its chief executive officer, Mr. Todd Davis is scheduled to present at both the CanEx Jamaica Business Conference & Expo on Sept. 27-28 at the Montego Bay Convention Center and at The MicroCap Conference in New York City on Oct. 1-2 at the JW Marriott Essex House.
The CanEx Jamaica Business Conference & Expo provides the industry with opportunities to create and build relationships, gain and share knowledge while learning about the latest cannabis innovations and business offerings.
At The MicroCap Conference Mr. Davis will appear on the Cannabis Panel that will take place on Oct. 1 at 5:30 p.m. ET. Mr. Davis will be delivering a presentation about Endexx’s extensive CBD line of products and provide recent updates on its AutoSpense™technology, the Company’s commercial-grade inventory control and dispensing device.
The MicroCap Conference is an exclusive event dedicated to connecting small and micro-cap companies with high-level, institutional and retail investors. The MicroCap Conference highlights the most attractive companies across various sectors. The MicroCap Conference brings up to 150 companies together with expert panels and speakers to present to the audience.
Management will be available throughout both conferences for one-on-one meetings with investors.
For more information on the conference or to schedule a one-on-one meeting, please visit the conference websites, https://canexjamaica.com/ and http://microcapconf.com.
Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites® is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 – the m3hub and the AutoSpense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical-grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The AutoSpense™ is a commercial-grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, AutoSpense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers.
Websites include: www.cbdunlimited.com,www.endexx.com and www.phytobites.com.
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
For further investor and media information, contact:
Chairman & CEO